Legend Biotech is a commercial-stage biotech company specializing in innovative cell therapies. Click here to find out why I ...

The complaint alleges nearly two dozen pharmaceutical companies colluded to limit competition, causing costs for certain generic medications to skyrocket.

Prior to joining Bright Minds, Dr. Collins simultaneously served as CEO of Biscayne Neurotherapeutics, a small molecule clinical stage company focused on CNS disorders, and CEO and President of ...

Berenberg Bank analyst Luisa Hector maintained a Hold rating on Novartis AG (NOVN – Research Report) today and set a price target of ...

This is the second volume of the Research Topic titled 'Novel Insights into CAR T-cell Associated Neurotoxicity'. You may ...

Bernstein analyst Florent Cespedes maintained a Buy rating on Novartis AG (NOVN – Research Report) today and set a price target of ...

This industry’s lobbying juggernaut has its claws in both sides of the aisle in Congress. In 2022, pharmaceutical and health ...

Second Circuit Partially Affirms Novartis’ Motion to Dismiss AKS Claims - Last week, the Second Circuit Court of Appeals affirmed ...

The Phase 3 STEER trial enrolled more than 100 children with SMA type 2, ages 2-17, who were able to sit, but hadn't walked ...

Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced the appointment of Dan Monahan as Chief Commercial Officer. Mr. Monahan will also join the Company’s Leadership ...

A webcast of the presentation will be accessible via the “Events & Presentations” section of Monte Rosa’s website at ir.monterosatx.com, and an archived version will be made available for 30 days ...

Versant Capital Management Inc boosted its holdings in shares of Novartis AG (NYSE:NVS – Free Report) by 782.0% in the fourth quarter, according to the company in its most recent 13F filing with the ...